Incidence rate of chronic kidney disease and its association with long‐term nonsteroidal anti‐inflammatory drug use in ankylosing spondylitis: A nationwide population‐based study
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15310 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Subin Hwang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, Renal Insufficiency, Chronic, Anti-Inflammatory Agents, Non-Steroidal, Databases, Factual. Die Arbeit nennt 27 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Aim
Ankylosing spondylitis (AS) predominantly affects the spine and sacroiliac joints, with rare renal involvement. We investigated the incidence rate and risk factors for chronic kidney disease (CKD) in patients with AS and its relationship with long‐term nonsteroidal anti‐inflammatory drug (NSAID) use.
Methods
We retrospectively analyzed data of patients diagnosed with AS from the Korean National Health Insurance service. The 3‐month, 6‐month, and 1‐year Assessment of SpondyloArthritis International Society (ASAS) NSAID Intake Scores were categorized into four groups, as follows: =0, >0 and ≤33.3, 33.3–66.6, and >66.6.
Results
Of the 12 000 patients with AS, 150 were identified with CKD, and the incidence rate was 4.64 per 10 000 patient‐years. Factors significantly associated with CKD included age ≥60 years, Charlson Comorbidity Index, hypertension, and diabetes mellitus. In the nested case–control analysis, among the ASAS NSAIDs Intake Scores for 0–365 days from diagnosis, the ≥66.6 group had a significantly lower odds ratio than those of the =0 group.
Conclusion
The present study established the incidence rate of CKD in Korean patients with AS. Though older age and comorbidities were found to be associated with a higher CKD risk, long‐term NSAID use was associated with a lower risk. Therefore, the optimal use of NSAIDs in inflammatory diseases requires extensive research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, South Korea.
- Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- Division of Rheumatology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang-si, Gyeonggi-do, South Korea.
ORCID-Profile: Soo Min Ahn, Bon San Koo
Förderung
- National Research Foundation of Korea
Zitieren
APA
Hwang, S., Kim, Y. J., Ahn, S. M., & Koo, B. S. (2024). Incidence rate of chronic kidney disease and its association with long‐term nonsteroidal anti‐inflammatory drug use in ankylosing spondylitis: A nationwide population‐based study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15310
Vancouver
Hwang S, Kim YJ, Ahn SM, Koo BS. Incidence rate of chronic kidney disease and its association with long‐term nonsteroidal anti‐inflammatory drug use in ankylosing spondylitis: A nationwide population‐based study. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15310
BibTeX
@article{Hwang2024,
author = {Hwang, Subin and Kim, Ye-Jee and Ahn, Soo Min and Koo, Bon San},
title = {Incidence rate of chronic kidney disease and its association with long‐term nonsteroidal anti‐inflammatory drug use in ankylosing spondylitis: A nationwide population‐based study},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15310}
}
EUVIMED